Biotech Stock Picking for Charity - 2006 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Stock Picking for Charity - 2006

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	12/28/2005 9:56:31 PM
	Read Replies (1) of 592

I'm not certain of the rules so I tried to copy what George did. If theres a fix needed thats fine. $200 pledged to the winner and in my case United Way BIVN - 10% - 10000 CRIS - 10% - 10000 FVRL - 10% - 10000 NTII - 10% - 10000 DSCO - 10% - 10000 GTXI - 10% - 10000 ARNA - 10% - 10000 GPCB - 10% - 10000 ARWR - 10% - 10000 PSDV - 10% - 10000 These two are off the beaten path. If their acceptable great - if not - I'll replace. PSDV pSivida Announces BrachySil(TM) Phase IIb Clinical Trials for Liver Cancer Commence Following Approval by HSA Monday October 31, 8:00 am ET First Patient in Multi-Center Dose-Profiling Study Receives Treatment in Singapore General Hospital after Approval by the Health Sciences Authority ARWR Arrowhead Accelerates Capital Contribution to Insert Therapeutics as Nanotech Cancer Drug Heads toward Human Clinical Trials Tuesday October 11, 7:00 am ET PASADENA, Calif.--(BUSINESS WIRE)--Oct. 11, 2005--Arrowhead Research Corp. (Nasdaq:ARWR - News), a diversified nanotechnology company providing the missing link between lab and marketplace, has accelerated its investment of an additional $3 million to majority-owned subsidiary Insert Therapeutics, Inc. regards, John McCarthy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next